Status:
COMPLETED
Comparison of PRS According to Inhalation Agent During LDLT
Lead Sponsor:
Seoul National University Hospital
Conditions:
Liver Transplantation
Postreperfusion Syndrome
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The investigators tried to evaluate the effect of desflurane on the incidence of postreperfusion syndrome during living donor liver transplantation surgery. The investigators used sevoflurane as a com...
Eligibility Criteria
Inclusion
- elective LDLT
Exclusion
- age \< 18, age \> 65
- patient refusal
- re-transplantation
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01886664
Start Date
December 1 2012
End Date
December 1 2013
Last Update
June 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Seoul, South Korea, 110-744